Skip to content
Screener

Total Revenue at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$1B-2.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$592.1M+1.1%
iRadimed logo
iRadimedIRMD
$21.98M+12.6%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$20.16M-48.5%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$872.3M+13.8%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$34.17M

Segments

By geography

See full
United States$2.41M
Switzerland$1.74M
Germany$691K
Japan$654K

By product

See full
Service$2.77M+12.5%

Other financials

Income statement

See full
Gross profit$1.2M+341%
Operating income-$12.3M-1.4%
Net income-$12.9M-9.0%
EPS (diluted)-$0.270.0%

Balance sheet

See full
Cash & equivalents$15.0M-19.6%
Total debt$23.5M+318%
Total equity$17.7M-67.5%
Total assets$58.5M-22.7%

Cash flow

See full
Operating cash flow-$12.7M-30.9%
CapEx$394.0K+23.5%
Free cash flow-$12.5M-24.0%

Valuation

See full
Market cap$83.77M-26.0%
Enterprise value$92.33M-7.8%
P/S2.4×-1.4×

Profitability

See full
Gross margin6.4%
Operating margin-141.5%-9.3pp
Net margin-145.6%-0.1pp
FCF margin-114.8%-9.6pp

Returns & leverage

See full
Return on equity-141.6%-501pp
Debt / equity1.3×+1.2×
Current ratio2.5×-1.1×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Rapid Micro Biosystems’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 7:33 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001380106-26-000101
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue:
Product revenue$5,286$4,802$10,864$8,903
Service revenue2,7682,4605,1925,564
Total revenue8,0547,26216,05614,467
Cost of revenue:
Cost of product revenue5,4345,31511,45910,344
Cost of service revenue1,4081,6723,0143,444
Total cost of revenue6,8426,98714,47313,788

Item 1. Financial Statements

FAQ

What is Rapid Micro Biosystems's total revenue?
Rapid Micro Biosystems (RPID) reported total revenue of $8.05M in Q2 2026.
How has Rapid Micro Biosystems's total revenue changed year-over-year?
Rapid Micro Biosystems's total revenue increased by 10.9% year-over-year, from $7.26M to $8.05M.
What is the long-term trend for Rapid Micro Biosystems's total revenue?
Over 4 years (2021 to 2025), Rapid Micro Biosystems's total revenue has grown at a 9.7% compound annual growth rate (CAGR), from $23.23M to $33.59M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Rapid Micro Biosystems's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude